DK174268B1 - 17-spiro-steroider, deres fremstilling samt lægemidler med indhold deraf - Google Patents

17-spiro-steroider, deres fremstilling samt lægemidler med indhold deraf Download PDF

Info

Publication number
DK174268B1
DK174268B1 DK198805090A DK509088A DK174268B1 DK 174268 B1 DK174268 B1 DK 174268B1 DK 198805090 A DK198805090 A DK 198805090A DK 509088 A DK509088 A DK 509088A DK 174268 B1 DK174268 B1 DK 174268B1
Authority
DK
Denmark
Prior art keywords
formula
compounds
compound
same meaning
pharmaceutically acceptable
Prior art date
Application number
DK198805090A
Other languages
Danish (da)
English (en)
Other versions
DK509088D0 (da
DK509088A (da
Inventor
Lucien Nedelec
Daniel Philibert
Andre Claussner
Martine Moguilewsky
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of DK509088D0 publication Critical patent/DK509088D0/da
Publication of DK509088A publication Critical patent/DK509088A/da
Application granted granted Critical
Publication of DK174268B1 publication Critical patent/DK174268B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
DK198805090A 1987-09-18 1988-09-13 17-spiro-steroider, deres fremstilling samt lægemidler med indhold deraf DK174268B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8712937A FR2620707B1 (fr) 1987-09-18 1987-09-18 Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR8712937 1987-09-18

Publications (3)

Publication Number Publication Date
DK509088D0 DK509088D0 (da) 1988-09-13
DK509088A DK509088A (da) 1989-05-23
DK174268B1 true DK174268B1 (da) 2002-10-28

Family

ID=9355024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198805090A DK174268B1 (da) 1987-09-18 1988-09-13 17-spiro-steroider, deres fremstilling samt lægemidler med indhold deraf

Country Status (18)

Country Link
US (1) US4921846A (de)
EP (1) EP0308345B1 (de)
JP (1) JP2794297B2 (de)
KR (1) KR960013446B1 (de)
CN (1) CN1031942C (de)
AT (1) ATE88716T1 (de)
CA (1) CA1340344C (de)
DE (1) DE3880601T2 (de)
DK (1) DK174268B1 (de)
ES (1) ES2054844T3 (de)
FR (1) FR2620707B1 (de)
GR (1) GR3008221T3 (de)
HU (1) HU199505B (de)
IE (1) IE61751B1 (de)
MX (1) MX174142B (de)
PT (1) PT88536B (de)
SU (1) SU1665877A3 (de)
ZA (1) ZA886820B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
EP0411733B1 (de) * 1989-08-04 1998-10-21 Schering Aktiengesellschaft 11 Beta-Aryl-gona-4,9-dien-3-one
FR2651233B1 (fr) * 1989-08-23 1991-12-13 Roussel Uclaf Nouveaux acides omega-phenylamino alcanouiques substitues sur le noyau aromatique par un radical derive de 19-norsterouides, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
DE4008584A1 (de) * 1990-03-15 1991-09-26 Schering Ag Verfahren zur herstellung von zwischenprodukten fuer die antigestagensynthese (onapristonsynthese)
DE69128820T2 (de) * 1990-08-14 1998-06-10 Hoechst Marion Roussel Inc Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
FR2757399B1 (fr) * 1996-12-23 1999-12-17 Hoechst Marion Roussel Inc Application de composes steroides substitues en 11 pour la fabrication de medicaments ayant une activite estrogene dissociee
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
EP2392258B1 (de) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-Informatiksystem
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
EP1862468A1 (de) * 2006-06-02 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364207A (en) * 1962-08-13 1968-01-16 Searle & Co Polyhydrospiro[estr/androst-4-ene-17, 2'-furan/pyran]-3-one and intermediates
US3422096A (en) * 1967-08-08 1969-01-14 Searle & Co Spiro(estrene/androstene-17,2'-oxetane)-3-one and intermediates
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
DE3026783C2 (de) * 1980-07-11 1982-07-29 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 5β-Hydroxy-δ↑6↑-steroiden
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
EP0116974B1 (de) * 1983-02-18 1986-10-29 Schering Aktiengesellschaft 11-Beta-Aryl-Estradiene, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant

Also Published As

Publication number Publication date
HU199505B (en) 1990-02-28
DE3880601D1 (de) 1993-06-03
DK509088D0 (da) 1988-09-13
SU1665877A3 (ru) 1991-07-23
HUT48275A (en) 1989-05-29
ES2054844T3 (es) 1994-08-16
JPH01106899A (ja) 1989-04-24
EP0308345B1 (de) 1993-04-28
CN1031942C (zh) 1996-06-05
CA1340344C (fr) 1999-01-26
DE3880601T2 (de) 1993-10-07
PT88536A (pt) 1988-10-01
KR960013446B1 (ko) 1996-10-05
KR890005143A (ko) 1989-05-13
IE882813L (en) 1989-03-18
CN1034207A (zh) 1989-07-26
FR2620707A1 (fr) 1989-03-24
MX174142B (es) 1994-04-25
PT88536B (pt) 1992-11-30
US4921846A (en) 1990-05-01
EP0308345A1 (de) 1989-03-22
FR2620707B1 (fr) 1989-12-08
JP2794297B2 (ja) 1998-09-03
GR3008221T3 (de) 1993-09-30
ZA886820B (en) 1989-11-29
ATE88716T1 (de) 1993-05-15
MX13052A (es) 1993-09-01
DK509088A (da) 1989-05-23
IE61751B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
DK174268B1 (da) 17-spiro-steroider, deres fremstilling samt lægemidler med indhold deraf
DK174211B1 (da) Steroider med en spiro-ring i 17-stillingen, deres fremstilling samt lægemidler med indhold deraf
AU635211B2 (en) 11 beta-substituted progesterone analogs
FI85274C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 11 -(4-isopropenylfenyl) estra-4,9-diener.
DE3886852T2 (de) 17-Aryl-Steroide, ihre Herstellung und Zwischenprodukte zu ihrer Herstellung, ihre Anwendung als Arzneimittel und pharmazeutische Zusammensetzungen, die sie enthalten.
EP2039701B1 (de) 20-Keto-11Beta-Arylsteroide und ihre Derivate mit agonistischen oder antagonistischen Hormoneigenschaften
IE54748B1 (en) Steroid compounds
AU8020887A (en) 17 alpha-(substituted-methyl)-17 beta-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
HU208021B (en) Process for producing 13-alyl-11-beta-phenyl-gonane derivatives and pharmaceutical compositions containing them
HU203764B (en) Process for producing 11-beta-4,9,15-estratiene derivatives and pharamceutical compositions containing them
IE67514B1 (en) 11beta-phenyl-14betaH steroids
JPH069685A (ja) １７位にメチレンラクトン基を含有する新規なステロイド、それらの製造法及び中間体、それらの薬剤としての使用並びにそれらを含有する製薬組成物
JP4476480B2 (ja) 新規な１１β位が置換された１９−ノルステロイド、それらの製造方法及び中間体、それらの薬剤しての使用並びにそれらを含有する製薬組成物
RU2137777C1 (ru) ПРОИЗВОДНЫЕ 11β-БЕНЗАЛЬДОКСИМ-ЭСТРА-4,9-ДИЕНА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
CA2614667C (en) 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
JP2009518347A (ja) Ｄ−ホモエストラ−４，９−ジエン−３−オンの１１β−ベンズアルドキシム誘導体類
MXPA00004712A (en) NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11&bgr;, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK